A new study looks at this area in order to provide evidence for key recommendations in the treatment of such patients.
Engine Biosciences bags $27M Series A extension to advance precision medicine platform in oncology
Engine Biosciences has raised $27 million in a Series A extension with an eye to advance its discovery-stage precision oncology programs, which leverage both machine